Skip to main content
. 2020 Mar 14;26:e920394-1–e920394-12. doi: 10.12659/MSM.920394

Figure 5.

Figure 5

MicroRNA-143 (miR-143) and the AKT signaling pathway in vitro. (A, B) Protein expression and the statistical analysis in H9C2 cells (n=6). (C) Representative images of immunoblots and quantitative data (n=6). (D, E) Malondialdehyde (MDA) and glutathione (GSH) levels in H9C2 cells (n=6). (F, G) Quantitative data on caspase-3 activity and cell viability in H9C2 cells (n=6). (H) MDA production (n=6). (I, J) Caspase-3 activity and cell viability detection in H9C2 cells (n=6). (K) The efficacy of the Ad-ca.Akt confirmed by immunoblot (n=6). Data are presented as the mean±standard deviation (SD) with the 95% confidence interval (CI). * P<0.05 versus the matched group.